| Product Code: ETC7663912 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Transarterial Chemoembolization (TACE) Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Transarterial Chemoembolization (TACE) Market - Industry Life Cycle |
3.4 Israel Transarterial Chemoembolization (TACE) Market - Porter's Five Forces |
3.5 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.6 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Transarterial Chemoembolization (TACE) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of liver cancer in Israel |
4.2.2 Technological advancements in transarterial chemoembolization procedures |
4.2.3 Growing demand for minimally invasive treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with transarterial chemoembolization procedures |
4.3.2 Limited awareness and accessibility of transarterial chemoembolization in certain regions of Israel |
5 Israel Transarterial Chemoembolization (TACE) Market Trends |
6 Israel Transarterial Chemoembolization (TACE) Market, By Types |
6.1 Israel Transarterial Chemoembolization (TACE) Market, By Procedure Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Procedure Type, 2021- 2031F |
6.1.3 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Conventional TACE, 2021- 2031F |
6.1.4 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By DEB-TACE, 2021- 2031F |
6.2 Israel Transarterial Chemoembolization (TACE) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Unresectable HCC, 2021- 2031F |
6.2.3 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Early-Stage HCC, 2021- 2031F |
6.3 Israel Transarterial Chemoembolization (TACE) Market, By Product Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Chemotherapeutic Agents, 2021- 2031F |
6.3.3 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Radiotherapeutic Agents, 2021- 2031F |
6.3.4 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Drug-eluting Particles, 2021- 2031F |
6.3.5 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Transarterial Chemoembolization (TACE) Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Surgical Centers, 2021- 2031F |
6.4.5 Israel Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Transarterial Chemoembolization (TACE) Market Import-Export Trade Statistics |
7.1 Israel Transarterial Chemoembolization (TACE) Market Export to Major Countries |
7.2 Israel Transarterial Chemoembolization (TACE) Market Imports from Major Countries |
8 Israel Transarterial Chemoembolization (TACE) Market Key Performance Indicators |
8.1 Number of hospitals/clinics offering transarterial chemoembolization services in Israel |
8.2 Patient satisfaction rates with transarterial chemoembolization procedures |
8.3 Number of research studies and clinical trials focused on improving transarterial chemoembolization techniques in Israel |
9 Israel Transarterial Chemoembolization (TACE) Market - Opportunity Assessment |
9.1 Israel Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
9.2 Israel Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Israel Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.4 Israel Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Transarterial Chemoembolization (TACE) Market - Competitive Landscape |
10.1 Israel Transarterial Chemoembolization (TACE) Market Revenue Share, By Companies, 2024 |
10.2 Israel Transarterial Chemoembolization (TACE) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here